Daily non-political popular news in brief.
On the road to a new cancer therapy -- starving the tumor
11-01-2007 · EurekAlert!VIB scientists connected to the Katholieke Universiteit Leuven, in collaboration with the Flemish biotech company ThromboGenics, have been studying the anticancer action of anti-PLGF. This substance appears not only successful in treatment of tumors for which the current therapies fail, but also contributes to the greater effectiveness of existing chemotherapy, without side effects. Thus, anti-PLGF might possibly form the basis for new treatment for cancer.
Read more »
Keywords: road, cancer, therapy, starving, tumor
« Previous | Next »
Similar news on "On the road to a new cancer therapy -- starving the tumor":
- Growth factor signals influence balance between normal growth and cancerous growth
11-09-2006 · EurekAlert!
Too much of a signaling protein called insulin-like growth factor-I (IGF-I) may fan the flames of cancer, while too little of the protein may cause short stature, dementia and osteoporosis. New research investigates how the growth hormone/IGF system is affected by the important tumor suppressor gene p53. This interplay of two signaling pathways reinforces questions about the long-term risks of prescribing growth hormone, while suggesting a future new avenue for cancer therapy.
Similar news · Read more »
- Taking Cancer's Fingerprint: Rapid genetic profiling for personalized therapy
02-17-2007 · Science News Online
A new, faster way to identify cancer-causing mutations in the DNA of tumor cells may pave the way for the next generation of custom-tailored cancer therapies.
Similar news · Read more »
- Scientists follow familiar TRAIL to new cancer therapy
07-09-2007 · EurekAlert!
A new study identifies a combination therapy that may sensitize human cancer cells to a promising treatment currently being used in clinical trials. The research, published in the July issue of the journal Cancer Cell, published by Cell Press, provides a pharmacological method for enhancing the potency and effectiveness of a tumor necrosis factor death receptor ligand against a variety of human cancers.
Similar news · Read more »
- Discovery of widespread tumor growth gene holds promise for effective anti-cancer treatment
09-23-2007 · EurekAlert!
Italian scientists will announce on Monday (Sept. 24) that they have found a new and promising target for anti-tumor therapy in cancer. Professor Saverio Alberti, from the CESI, University of Chieti Foundation, Chieti, will tell the European Cancer Conference that he and his team have found a widespread mechanism for the stimulation of tumor growth in man, and that this is leading to the development of novel diagnostic and therapeutic procedures.
Similar news · Read more »
- Scripps Research study reveals new function of protein kinase pathway in tumor suppression
01-25-2007 · EurekAlert!
Scientists at the Scripps Research Institute have discovered a surprising new function of a well-known signaling pathway that, when activated, can inhibit tumor development. This finding may lead to the development of drugs that can serve as an effective cancer therapy by artificially activating this pathway in cancer cells.
Similar news · Read more »
- Women with breast cancer have less dermatitis when treated with IMRT
10-28-2007 · EurekAlert!
All women treated with radiation therapy for breast cancer are at risk of developing dermatitis -- a sometimes-painful skin condition caused by radiation as it makes its way through the skin to the tumor area and tissue within the breast. But researchers at Fox Chase Cancer Center say women being treated with intensity-modulated radiation therapy are less likely to have serious dermatitis.
Similar news · Read more »
- Blood-vessel blocker aids cancer-killing virus
11-27-2007 · EurekAlert!
Cancer-killing viruses are a promising therapy for incurable brain tumors, but their effectiveness has been limited in part because immune cells rapidly eliminate them. That immune response might be slowed, and the virus given more time to kill cancer cells, by blocking the growth of blood vessels in the tumor, new Ohio State research suggests. The study indicates that pretreatment with a drug that blocks blood-vessel growth might improve the effectiveness of cancer-killing viruses.
Similar news · Read more »
- JCI table of contents: June 7, 2007
06-07-2007 · EurekAlert!
This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online June 7, 2007, in the JCI, including: "Combination therapy reduces tumor resistance to radiation"; "Improved prediction of prostate cancer recurrence"; "Role of GM-CSF in the immune response to tumors"; "Protein C signaling impacts inflammatory bowel disease"; "Iron imbalance in anemia: Hints from HIF"; and "Phosphorylation state of eNOS is key to blood vessel function."
Similar news · Read more »
- Nodal status is best predictor of outcome after neoadjuvant therapy for esophageal cancer
07-13-2007 · EurekAlert!
The number of lymph nodes that contain evidence of cancer is the best predictor of the effectiveness of adding chemotherapy and radiation to a treatment plan prior to surgery in individuals with esophageal cancer, according to a study published last month in the Annals of Surgery. The authors say their finding is particularly important because the focus of recent pathological studies of response to neoadjuvant therapies has been on the primary tumor rather than nodal sites.
Similar news · Read more »
- Tumor Suicide: Gene therapy makes cancer cells self-destruct
07-14-2007 · Science News Online
Microscopic bubbles of fat that deliver a suicide gene to tumor cells show success in treating pancreatic cancer in mice.
Similar news · Read more »
